News


25 - 36 of 102 items

Commission supports 225 reform projects in Member States to improve their resilience, create jobs and growth

Commission supports 225 reform projects in Member States to improve their resilience, create jobs and growth

Thursday, 10 de March de 2022

The Commission approved 225 projects under the Technical Support Instrument (TSI), to support Member States in preparing, designing and implementing reforms that will lead to modern and resilient public administrations, sustainable growth strategies and resilient economies while enhancing their capacity to react to current and future crises. The 2022 TSI Work Programme also includes some novelties like the multi-country or multi-region projects, as well as the flagship projects. 

Almost 15% of Europes adults have a ringing in their ears, say researchers

Almost 15% of Europes adults have a ringing in their ears, say researchers

Tuesday, 8 de March de 2022

More than 1 in 7 adults in Europe experience a high-pitched ringing in the ears called tinnitus, according to a recent study supported by the EU-funded ESIT, UNITI and GENDER NET Plus projects. The current study is most likely the first of its kind to have collected multinational data on tinnitus using the same standardised survey questions and response options across 12 European countries. 

Two compounds progress to phase 1 trials, offering hope for new cancer drugs

Two compounds progress to phase 1 trials, offering hope for new cancer drugs

Tuesday, 1 de March de 2022

The Innovative Medicines Initiative’s European Lead Factory, a screening service with a vast chemical library, has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing. An Israeli SME called Metabomed and the German pharmaceutical company Merck KGaA, have both recently identified compounds in ELF’s high-quality compound collection that show promise in inhibiting their target pathways, both of which are involved in the development of tumours.

Getting ever closer to blood-based biopsies for detecting and monitoring tumours

Getting ever closer to blood-based biopsies for detecting and monitoring tumours

Tuesday, 1 de March de 2022

The European Liquid Biopsy Society, an offshoot of the IMI project CANCER-ID, is pushing the science on liquid biopsies closer to clinical reality. The ability to detect and study tumours through a mere blood sample – a minimally invasive procedure – would have huge implications, and a lot of progress has been made in the development of different technologies that achieve this ambitious goal.

European Health Union: new rules to improve clinical trials in the EU

European Health Union: new rules to improve clinical trials in the EU

Monday, 28 de February de 2022

On Monday 31st January,  the assessment and supervision of clinical trials throughout the EU was harmonised, notably via a Clinical Trials Information System (CTIS) run by the European Medicines Agency. From this date the Regulation on Clinical Trials have entered into application. This Regulation improves conducting clinical trials in the EU, with the highest standards of safety for participants and increased transparency of trial information. 

New AI Tool Detects Often Overlooked Heart Diseases

New AI Tool Detects Often Overlooked Heart Diseases

Thursday, 24 de February de 2022

Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis,  two life-threatening heart conditions that are often easy to miss. The two-step, novel algorithm identifies specific features - related to the thickness of heart walls and the size of heart chambers - to efficiently flag certain patients as suspicious for having the potentially unrecognized cardiac diseases.

Air pollution linked to adverse brain outcomes in children

Air pollution linked to adverse brain outcomes in children

Tuesday, 22 de February de 2022

The Health Effects Institute has conducted a research which has documented associations between early life air pollution exposure and various measures of brain structural morphology, structural connectivity, and functional connectivity in children. But further analyses in this topic are encouraged. 

European Health Union: new rules to improve clinical trials in the EU

European Health Union: new rules to improve clinical trials in the EU

Monday, 31 de January de 2022

As of Monday 31 January,  the assessment and supervision of clinical trials throughout the EU will be harmonised, notably via a Clinical Trials Information System (CTIS) run by the European Medicines Agency. On this date the Regulation on Clinical Trials will enter into application. This Regulation will improve conducting clinical trials in the EU, with the highest standards of safety for participants and increased transparency of trial information

Investigating blood flow in severe COVID-19 patients

Investigating blood flow in severe COVID-19 patients

Monday, 31 de January de 2022

Researchers supported by the EU-funded LUCA, VASCOVID and LASERLAB-EUROPE projects studied COVID-19 from a different perspective. In what is likely the first study of its kind, they examined how the disease affected microcirculation – the circulation of blood in the smallest blood vessels – in seriously ill COVID-19 patients. 

Needle-free diabetes monitoring

Needle-free diabetes monitoring

Monday, 24 de January de 2022

Continuous glucose monitoring is the gold standard approach for diabetes management. An under-the-skin sensor is expected to make finger pricking and visible patches a thing of the past.

2022 EU4Health work programme adopted to invest over 835 million in health

2022 EU4Health work programme adopted to invest over 835 million in health

Monday, 17 de January de 2022

In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for the European Health Union. With a budget of over €835 million, the new work programme will provide an unparalleled level of EU investment in health and ensure ambitious and decisive action in four focus areas: crisis preparedness, disease prevention, health systems and healthcare workforce, and digitalisation.